Andrx/Aventis Settle With FTC: Agency Says Cardizem CD Generic Not Delayed

Aventis and Andrx' consent agreement with the Federal Trade Commission includes an acknowledgement by the agency that the patent litigation settlement between the two companies did not delay the advent of generic competition to Cardizem CD.